Apyx Medical (APYX) Competitors $1.19 +0.02 (+1.71%) (As of 11/1/2024 ET) Add Compare Share Share Competitors Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSustainabilityTrends APYX vs. CODX, ICAD, TELA, TTOO, PYPD, BWAY, DRTS, PDEX, GUTS, and LAKEShould you be buying Apyx Medical stock or one of its competitors? The main competitors of Apyx Medical include Co-Diagnostics (CODX), iCAD (ICAD), TELA Bio (TELA), T2 Biosystems (TTOO), PolyPid (PYPD), BrainsWay (BWAY), Alpha Tau Medical (DRTS), Pro-Dex (PDEX), Fractyl Health (GUTS), and Lakeland Industries (LAKE). These companies are all part of the "medical equipment" industry. Apyx Medical vs. Co-Diagnostics iCAD TELA Bio T2 Biosystems PolyPid BrainsWay Alpha Tau Medical Pro-Dex Fractyl Health Lakeland Industries Apyx Medical (NASDAQ:APYX) and Co-Diagnostics (NASDAQ:CODX) are both small-cap medical companies, but which is the superior business? We will contrast the two businesses based on the strength of their institutional ownership, media sentiment, community ranking, valuation, profitability, risk, dividends, earnings and analyst recommendations. Do analysts prefer APYX or CODX? Apyx Medical presently has a consensus price target of $5.00, suggesting a potential upside of 320.17%. Co-Diagnostics has a consensus price target of $1.50, suggesting a potential upside of 23.97%. Given Apyx Medical's stronger consensus rating and higher possible upside, equities analysts plainly believe Apyx Medical is more favorable than Co-Diagnostics.Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Apyx Medical 0 Sell rating(s) 2 Hold rating(s) 1 Buy rating(s) 1 Strong Buy rating(s) 2.75Co-Diagnostics 0 Sell rating(s) 1 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 2.00 Do institutionals & insiders hold more shares of APYX or CODX? 55.3% of Apyx Medical shares are owned by institutional investors. Comparatively, 15.0% of Co-Diagnostics shares are owned by institutional investors. 16.8% of Apyx Medical shares are owned by insiders. Comparatively, 6.1% of Co-Diagnostics shares are owned by insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a company is poised for long-term growth. Is APYX or CODX more profitable? Apyx Medical has a net margin of -57.86% compared to Co-Diagnostics' net margin of -411.18%. Co-Diagnostics' return on equity of -44.69% beat Apyx Medical's return on equity.Company Net Margins Return on Equity Return on Assets Apyx Medical-57.86% -105.45% -36.80% Co-Diagnostics -411.18%-44.69%-40.47% Does the media favor APYX or CODX? In the previous week, Apyx Medical had 1 more articles in the media than Co-Diagnostics. MarketBeat recorded 1 mentions for Apyx Medical and 0 mentions for Co-Diagnostics. Apyx Medical's average media sentiment score of 1.31 beat Co-Diagnostics' score of -0.50 indicating that Apyx Medical is being referred to more favorably in the media. Company Overall Sentiment Apyx Medical Positive Co-Diagnostics Negative Which has stronger valuation and earnings, APYX or CODX? Apyx Medical has higher revenue and earnings than Co-Diagnostics. Apyx Medical is trading at a lower price-to-earnings ratio than Co-Diagnostics, indicating that it is currently the more affordable of the two stocks. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioApyx Medical$52.35M0.79-$18.71M-$0.82-1.45Co-Diagnostics$9.14M4.23-$35.33M-$1.26-0.96 Does the MarketBeat Community believe in APYX or CODX? Co-Diagnostics received 195 more outperform votes than Apyx Medical when rated by MarketBeat users. Likewise, 63.05% of users gave Co-Diagnostics an outperform vote while only 60.94% of users gave Apyx Medical an outperform vote. CompanyUnderperformOutperformApyx MedicalOutperform Votes7860.94% Underperform Votes5039.06% Co-DiagnosticsOutperform Votes27363.05% Underperform Votes16036.95% Which has more volatility & risk, APYX or CODX? Apyx Medical has a beta of 1.2, meaning that its stock price is 20% more volatile than the S&P 500. Comparatively, Co-Diagnostics has a beta of -0.84, meaning that its stock price is 184% less volatile than the S&P 500. SummaryApyx Medical beats Co-Diagnostics on 14 of the 19 factors compared between the two stocks. Ad Daily Market AlertsInvest in the AI Boom: Top 5 Stocks to WatchBy now, you're well aware of the artificial intelligence boom. Big Tech has been investing billions of dollars into AI, and the market is projected to grow exponentially. According to several recent reports, the AI market, currently valued at around $100 billion, could grow twenty-fold by 2030 to more than $2 trillion. This explosive growth means it's time to consider these top AI stocks. [Click Here to Automatically Download Your Free eBook Now] Get Apyx Medical News Delivered to You Automatically Sign up to receive the latest news and ratings for APYX and its competitors with MarketBeat's FREE daily newsletter. Email Address New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding {thisCompany.Symbol} and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart APYX vs. The Competition Export to ExcelMetricApyx MedicalSurgical & medical instruments IndustryMedical SectorNASDAQ ExchangeMarket Cap$41.22M$4.41B$5.54B$8.53BDividend YieldN/A42.37%5.13%4.14%P/E Ratio-1.4538.74114.8115.14Price / Sales0.7965.081,495.55100.10Price / CashN/A49.0939.6734.08Price / Book1.534.264.665.02Net Income-$18.71M$11.52M$119.06M$225.46M7 Day Performance-1.65%1.06%0.80%0.37%1 Month PerformanceN/A0.92%5.65%3.57%1 Year Performance-52.40%39.37%36.75%29.43% Apyx Medical Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)APYXApyx Medical4.5083 of 5 stars$1.19+1.7%$5.00+320.2%-49.1%$41.22M$52.35M-1.45270Upcoming EarningsCODXCo-Diagnostics3.2389 of 5 stars$1.21-0.8%$1.50+24.0%+13.1%$38.61M$6.81M-0.96100Upcoming EarningsShort Interest ↑ICADiCAD0.464 of 5 stars$1.89+1.6%N/A+37.9%$50.16M$17.32M-17.1867Short Interest ↑TELATELA Bio3.285 of 5 stars$2.75-2.1%$10.00+263.6%-49.7%$67.95M$58.45M-1.60120Upcoming EarningsTTOOT2 Biosystems2.1548 of 5 stars$0.88+0.6%$5.00+467.7%-85.7%$15.40M$7.16M0.00180PYPDPolyPid2.2833 of 5 stars$3.20-9.6%$14.00+337.5%-14.3%$15.36MN/A-0.3280Gap DownBWAYBrainsWay3.0354 of 5 stars$10.00+0.5%$13.17+31.7%+180.3%$166.80M$31.78M200.04120Gap UpDRTSAlpha Tau Medical2.151 of 5 stars$2.34+5.4%$8.00+241.9%-32.7%$163.03MN/A-5.8580Gap UpPDEXPro-Dex1.6513 of 5 stars$45.29+46.0%$30.00-33.8%+108.7%$150.50M$53.84M73.05140News CoverageGap UpHigh Trading VolumeGUTSFractyl Health1.6187 of 5 stars$2.99+6.0%$22.00+635.8%N/A$143.31M$120,000.000.00102Gap UpLAKELakeland Industries4.8669 of 5 stars$18.39-1.1%$26.50+44.1%+34.7%$136.09M$124.69M76.631,750Analyst DowngradeNews Coverage Related Companies and Tools Related Companies CODX Competitors ICAD Competitors TELA Competitors TTOO Competitors PYPD Competitors BWAY Competitors DRTS Competitors PDEX Competitors GUTS Competitors LAKE Competitors Top 10 Stock Comparisons Bank Stocks Artificial Intelligence Stocks Toy Stocks Growth Stocks Airline Stocks Chinese Stocks EV Charging Stocks Defense Stocks Lithium Stocks Pharmaceutical Stocks This page (NASDAQ:APYX) was last updated on 11/2/2024 by MarketBeat.com Staff From Our Partners625,000% GainImagine swapping your daily coffee expense for a future free of financial worries. It might seem far-fetche...Crypto Swap Profits | SponsoredEx WH Advisor Who Predicted Biden Leaving Race Makes Startling New PredictionFormer advisor to the CIA, the Pentagon and the White House Jim Rickards went on multiple TV news programs… ...Paradigm Press | SponsoredMarket "Famine" ComingMarket Wizard Larry Benedict accurately predicted that all indexes would be negative in 2022... He predicte...Opportunistic Trader | SponsoredMusk Says ‘Dollar Will Be Worth Nothing…’Elon Musk just issued an urgent warning… It's no secret that Musk is able to move markets with his words…Crypto 101 Media | Sponsored[Just Released] Jovine's Emergency Briefing insidePeople didn't believe Jovine when he predicted the 2008 financial crisis over a year in advance. But some read...Behind the Markets | SponsoredHe made 1,303,329 in 12 months after Biden won…Tim Sykes - the world’s most apolitical Millionaire trader - just sat down for an urgent election interview… ...Timothy Sykes | SponsoredMost People Are Dead Wrong.Turn on any financial news outlet at any given moment and within minutes you're guaranteed to see headlines ab...Brownstone Research | SponsoredSell NVDA Now?Guess who's selling NVDA next The most successful hedge fund in history quietly sold 500,000 shares. Here's...Chaikin Analytics | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Apyx Medical Co. Please log in to your account or sign up in order to add this asset to your watchlist. Share Apyx Medical With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
